Patient engagement in first cycle comprehensive chemotherapy consultation pharmacist services and impact on patient activation

Abstract

Background: Healthcare systems and policy makers worldwide are demonstrating interest in shared decision making, which requires patient activation. Patient activation can be measured using a validated tool called the patient activation measure-10. First cycle comprehensive chemotherapy consultation services (3CS) is provided by an oncology pharmacy team member during a patient encounter at the beginning of the patient's treatment for cancer. Methods: This was a single center, prospective, non-randomized, observational clinical study in patients with cancer who required a new chemotherapy plan. A baseline patient activation measure-10 survey was administered and a pharmacy team member met with the patient to complete the first cycle 3CS encounter. Within two business days of that encounter, a second patient activation measure-10 survey was administered, and thus, patients served as their own control. Results: Forty-nine patients who met the inclusion criteria were enrolled, of which 36 completed the study. Mean patient activation measure-10 scores measured at baseline and two business days after the 3CS encounter were significantly different (68.5 AE SD 14.7 vs. 75.0 AE SD 14.3, p ¼ 0.001). This difference persisted when evaluated by gender (female: 70.0

Addressing Hidden Curricula That Subvert the Patient-Centeredness “Hub” of the Pharmacists’ Patient Care Process “Wheel”

“…Examples of sources screened out for "Perfunctory Use" defined patient-centered care as any pharmacist service delivered within a Patient-Centered Medical Home, 17 any course in Clinical, Social or Experiential Pharmacy, 18 or used the terminology imprecisely. 19 Examples of sources deemed ineligible for "Insubstantial Use" were publications that appropriately used terms and concepts like shared decision-making, 20 patient-focused care, 21 patient engagement, 22 and patient self-management 23 but lacked operational depth or theoretical exploration applied to patient-centeredness. From the 21 sources selected for categorization and qualitative synthesis, seven classified as "Pharmacy Only," four as "Seminal Only," and 10 as "Pharmacy & Seminal."…”

Quality of Life Among Breast and Colon Cancer Patients Before and After First-Cycle Chemotherapy

“…Raising the importance of assessing the QoL of patients with cancer during the first stage of chemotherapeutic management provides impetus to develop evidence-based and individualized supportive care along the course of cancer treatment. Bates et al (2019), for example, indicated the need to provide FC chemotherapy counseling services to patients with cancer to promote patient engagement and shared decision making on their plan of care. This study serves as a basis in developing a comprehensive and holistic care management plan that supports and alleviates the unfavorable effects of chemotherapeutic treatment and implements interventions that aid in the improvement of overall QoL.…”

Reduced emergency room visits and improved medication adherence of an integrated oncology pharmaceutical care practice in China

“…Obviously, the roles of oncology pharmacists in oncology practice are well established in monitoring anticancer drugs, 1 increasing patient engagement in chemotherapy, 2 optimizing therapy effectiveness and preventing adverse effects, 3 improving the safety of chemotherapy, 4,5 medication beliefs and adherence 6 as well as pharmacovigilance. 7 Furthermore, a limited number of reports have described the vital role of clinical pharmacists in interprofessional precision medicine initiatives in oncology practice in the United States.…”